A clinical trial carried out over 98 days was done to evaluate treatme
nt of horses with moxidectin gel for efficacy as measured by (I) reduc
tion in the production of parasite ova post treatment, (2) a compariso
n of the posttreatment parasite egg count suppression of moxidectin to
ivermectin, and (3) assessment of the field safety, animal acceptance
of the moxidectin formulation, and the utility of the moxidectin deli
very device. One hundred and fifty Standardbred horses with naturally
acquired parasite infections were used in the study. Moxidectin had mo
re prolonged and greater suppressive influence than did ivermectin on
reappearance and magnitude of strongyle egg counts post treatment, Dif
ferences were not observed between the capability of ivermectin or mox
idectin to reduce and suppress low Parascaris equorum egg counts. Adve
rse reactions to treatments were not observed, and the utility of the
moxidectin delivery syringe and animal acceptance of moxidectin treatm
ent were satisfactory. (C) 1997 Elsevier Science B.V.